Back to today’s briefing

Story perspectives

Atai Life Sciences Invests $5M in Bitcoin for Growth

3/23/2025

50 9

Summary

Story summary

Atai Life Sciences, a Berlin-based biopharmaceutical company, has boldly invested $5 million in Bitcoin to combat inflation and secure its financial future. This strategic move not only aims to bolster operations through 2027 but also addresses critical gaps in mental health care. Recently, the firm completed phase 2b trials for BPL-003, focusing on treatment-resistant depression.

1 of 1

Story summary

Atai Life Sciences, a Berlin-based biopharmaceutical company, has boldly invested $5 million in Bitcoin to combat inflation and secure its financial future. This strategic move not only aims to bolster operations through 2027 but also addresses critical gaps in mental health care. Recently, the firm completed phase 2b trials for BPL-003, focusing on treatment-resistant depression.